JWA
RLAY icon

JFS Wealth Advisors’s Relay Therapeutics RLAY Stock Holding History

JFS Wealth Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$9 – 2033
2023
Q3 		$9 Sell
1
-5
-83% -$54 ﹤0.01% 1967
2023
Q2 		$76 Sell
6
-4
-40% -$50 ﹤0.01% 1935
2023
Q1 		$165 Buy
10
+5
+100% +$90 ﹤0.01% 1843
2022
Q4 		$75 Sell
5
-3
-38% -$57 ﹤0.01% 1901
2022
Q3 		$0 Sell
8
-2
-20% -$44 ﹤0.01% 1898
2022
Q2 		$0 Buy
+10
New +$214 ﹤0.01% 1906

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JFS Wealth Advisors's RLAY Position: Q4 2023 in Review

JFS Wealth Advisors sold out of Relay Therapeutics (RLAY) in Q4 2023, closing a stake of 1 share — an estimated $9 sold.

JFS Wealth Advisors first reported a position in RLAY in Q2 2022 and held it in 6 quarters. The position peaked at $165 in Q1 2023. 177 funds tracked by Wall St. Rank hold RLAY as of Q4 2023.

  • JFS Wealth Advisors reported no remaining Relay Therapeutics position as of Q4 2023 after selling out during the quarter.
  • JFS Wealth Advisors sold 1 Relay Therapeutics share in Q4 2023, an estimated $9.
  • JFS Wealth Advisors first reported a position in Relay Therapeutics in Q2 2022 and held it in 6 quarters.
  • JFS Wealth Advisors's Relay Therapeutics position peaked at $165 in Q1 2023.
  • 177 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2023.

Based on JFS Wealth Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.